Tirzepatide Dosing Schedule: Mounjaro and Zepbound
Current adult Mounjaro and Zepbound labels start tirzepatide at 2.5 mg once weekly, increase to 5 mg after four weeks, and permit further 2.5 mg increases only after at least four weeks on the current dose when the label's conditions are met. That does not make every listed strength a mandatory step or create one identical maintenance plan for every indication and population.
Use the current Mounjaro prescribing information or Zepbound prescribing information for the exact product. Mounjaro now includes population-specific instructions, and Zepbound maintenance choices depend on indication.
The Shared Adult Initiation Framework
| Stage | Label framework |
|---|---|
| Initiation | 2.5 mg once weekly |
| After four weeks | Increase to 5 mg once weekly |
| Further increases | 2.5 mg increments only after at least four weeks on the current dose, if indicated |
| Maximum | Follow the exact product and population label; adult maximum is 15 mg once weekly in the cited schedules |
This is a framework, not a calendar promising that a patient will reach 15 mg. The prescriber chooses maintenance treatment based on the product's indication, response, tolerability, and label.
Not Every Strength Is a Required Stop
Tirzepatide products are available in multiple strengths, including 2.5, 5, 7.5, 10, 12.5, and 15 mg. A list of strengths is not a six-step program that every patient completes.
The labels distinguish initiation, escalation, and maintenance. For Zepbound, maintenance recommendations vary by indication. For Mounjaro, the clinician considers glycemic goals and the applicable adult or pediatric instructions. Do not build a personal schedule by advancing every four weeks automatically.
The Four-Week Minimum Is Not a Deadline
“After at least four weeks” sets a lower boundary for further increases under the label; it does not require an increase on day 29. It also does not establish an eight-week hold rule, a standard dose-down-and-rechallenge plan, or a fixed time to maximum dose.
If adverse reactions occur, contact the prescriber. Do not hold, reduce, repeat, or advance a dose based on a generic online calendar.
Mounjaro and Zepbound Are Not Fully Interchangeable
They contain the same active ingredient and share strengths, but they have different indications and product-specific maintenance language. The current Mounjaro label includes type 2 diabetes treatment in adults and pediatric patients 10 years and older. The current Zepbound label includes chronic weight management and moderate-to-severe obstructive sleep apnea in defined populations.
A brand switch needs a prescription and pharmacist confirmation. Do not assume a schedule carries across automatically.
Missed Doses and Day Changes
Both cited labels provide instructions involving a missed dose within four days and at least 72 hours between doses when changing the weekly administration day. Read the exact label before acting, especially after multiple missed doses or a prescription change.
Do not take an extra dose because a calendar looks incomplete. Contact the pharmacist or prescriber when dates are uncertain.
Tracking the Prescribed Schedule
Record the exact brand, dose, administration date, and any clinician-directed change. A timeline can help identify what was actually taken; it does not choose the next strength or judge whether a dose is effective.
OffGrid Dose can organize those entries and reminders. The app stores its working data on your iPhone and has no OffGrid Dose account, company-operated cloud sync, or server-side health database. Depending on your Apple and device settings, an encrypted device backup may include app data.
Frequently Asked Questions
Are the Mounjaro and Zepbound schedules identical?
They share an adult initiation framework and strengths, but indications, population-specific instructions, and maintenance choices differ. Use the exact product label.
How long does it take to reach 15 mg?
There is no promised timeline and no requirement that a patient reach 15 mg. The four-week language is a minimum before a possible increase, not an automatic calendar.
What if symptoms occur after an increase?
Contact the prescriber and follow the product's symptom instructions. Do not predict a fixed peak-and-resolution course or alter the dose yourself.
Can I stay at a lower strength?
The prescriber selects maintenance treatment from the choices allowed for the product, indication, and population. Do not infer the correct long-term dose from another person's schedule.
This article is for informational purposes only and does not constitute medical advice. Tirzepatide dosing must follow the current exact product label and the prescribing clinician's directions.
Related Articles
Track this with OffGrid Dose
Log every dose, rotate injection sites, and watch your weight trend in a private local working log.
Mounjaro tracker →